Vishal Shah

6PUBLICATIONS
68CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Clinical pharmacy and pharmacy practiceHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 05, 2024
Reducing Cancer Drug Cost: 3-Year Analysis of Automated Dose Rounding in Electronic Health Records.

Vishal S Shah, Clayton Irvine, Robert R McWilliams

|Aug 02, 2024
Oncology stewardship practice in the United States: A Hematology/Oncology Pharmacy Association national survey.

Marisela Tan Banez, Sol Atienza, Allison Butts

|Nov 17, 2023
Evaluating the Impact of Pharmacist Dual Verification of Anticancer Therapy in the Modern Era.

Devon S Stonerock, Kaylee Clark, Vishal Shah

|May 16, 2023
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.

Talal El Zarif, Amin H Nassar, Elio Adib

|Mar 29, 2023
Amivantamab-Vmjw: A Novel Treatment for Patients with NSCLC Harboring EGFR Exon 20 Insertion Mutation after Progression on Platinum-Based Chemotherapy.

Vishal Shah, Andrea McNatty, Lacey Simpson

|Feb 09, 2022
Abemaciclib: The First FDA-Approved CDK4/6 Inhibitor for the Adjuvant Treatment of HR+ HER2- Early Breast Cancer.

Farah Raheem, Henry Ofori, Lacey Simpson

Pageof 1

Frequent Collaborators

2 joint publications

Lacey Simpson

1 joint publications

Clayton Irvine

1 joint publications

Robert R McWilliams

1 joint publications

Scott A Soefje